[extropy-chat] Lifeline Nutraceuticals and Ceremedix news

Robert J. Bradbury bradbury at aeiveos.com
Wed Jan 7 12:40:13 UTC 2004



On Wed, 7 Jan 2004, Giu1i0 Pri5c0 wrote:

> >From the Lifeline Nutraceuticals and Ceremedix websites and mailing lists:

[snip]

I would be *highly* doubtful...  Sounds too much like a scam to me.

> Lifeline has a unique anti-aging nutraceutical, protandim (TM),

But *what* is it?

> ... the effects of "oxidative stress" caused by aging and numerous diseases.

Hmmm... the conventional wisdom is that oxidative stress causes aging
not aging causes oxidative stress.  (Living does cause oxidative stress
but without consuming oxygen we wouldn't be able to live.)

> CereMedix has a unique portfolio of peptide-based product candidates

If they are unique then there should be patents and one should not have
a problem disclosing them right?

Furthermore if they are peptides (sequences of amino-acids) then one
has a problem getting them through the digestive tract without being
broken down.  So they would need to be injected right?  If they are
overloading the digestive tract so some peptides might be absorbed
how do they account in individual differences in digestive capacity?

> with the unique action of activating certain genes present in cells

What genes precisely?

> of the human body that act as the bodys own defend and
> repair mechanisms.

Hmmm... presumably that is "defense and repair".  Mind you there are
substances that activate the Phase II detoxification system which
are in foods like brocolli and perhaps garlic.  Google on sulphorophane
or allicin and "Phase II".

Unless they point out something concrete that is novel I'd stick
with substances that are known, the subject of public studies
and probably much cheaper.

> The company is targeting its therapeutic products at multi-billion
> dollar markets with no viable existing therapeutics.

Well that statement is obligatory otherwise why would anyone be
interested?

Robert





More information about the extropy-chat mailing list